Ray Care SRL
21.7 FTERay Care reported total assets of €2.70m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Sep 2026), with 21.7 full-time equivalents.
The score of Ray Care shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +12411 % Total assets +705 % Headcount (avg FTE) +1106 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ray Care's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Sep 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 27 May 2024
- Year ended 31 Dec 2022filed on 30 Sep 2023
Ray Care's financial analysis
- Solvency41.4%sector median: 31.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ray Care
Ray Care's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0764.486.593
- VAT number
- BE0764486593
- Peppol
- Registered · 0208:0764486593 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Mar 2021
- Registered office
- 9000 Ghent
- Size
- Small · 21.7 FTE
- Latest accounts
- 2025 · filed on 02 Sep 2026
- Activity
- Manufacture of perfume and toilet preparations (NACE 20420)
Ray Care (SRL) has been based in Ghent since 2021, active in: manufacture of perfume and toilet preparations. For 2025, it reports a net profit of 961,581 € and equity of €1.12m; its revenue is not published. With 21.7 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 41.4%, above the median of its sector (31.9%).
Companies similar to Ray Care
Companies in the same business, of comparable size and area, outside its group.
- Laboratoires DE Biarritz International Manufacture of perfume and toilet preparations Waterloo · balance sheet €2.34m
- CosmXpert Manufacture of perfume and toilet preparations Brussels · balance sheet €1.45m
- Carin Haircosmetics Manufacture of perfume and toilet preparations Middelkerke · balance sheet €3.08m
- Naturalis-Cosmetics Manufacture of perfume and toilet preparations Diepenbeek · balance sheet €2.28m
- Bio-Essentials Wholesale of perfume and cosmetics Turnhout · balance sheet €1.48m
- A.M.'s Manufacture of perfume and toilet preparations Schaerbeek · balance sheet €1.02m
- Aphrodites Amphora Cosmetics Manufacture of perfume and toilet preparations Wevelgem · balance sheet 950,692 €
- SISLEY Belgique Manufacture of perfume and toilet preparations Brussels · balance sheet €7.94m
Frequently asked questions about Ray Care
What is the revenue of Ray Care?
Ray Care files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ray Care?
In Belgium, the VAT number is the company number prefixed with BE: BE0764486593 for Ray Care, if the company is VAT-registered. Its company number (CBE) is 0764.486.593.
Where is the registered office of Ray Care?
According to the CBE register, the registered office of Ray Care is in 9000 Ghent.
What is the equity of Ray Care?
At the close of the 2025 financial year, the equity of Ray Care amounts to 1,117,440 €, a solvency of 41.4% of total assets.
How many people work at Ray Care?
21.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Ray Care?
The register lists 5 active mandates at Ray Care. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ray Care
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →